Dr Hanna’s research interests are the use of PET/CT in radiotherapy planning for lung cancer, overcoming radiotherapy resistance, stereotactic ablative radiotherapy and systemic therapy and immunotherapy/radiotherapy combinations.
He is co-chief Investigator of the CONCORDE study, a proposed UK study of novel agents with radiotherapy in the treatment of lung cancer.
Dr Hanna is open to PhD applications in the fields of;
Clinical and Scientific PhD and MD Fellowships in breast and lung cancer, with an emphasis on treatment with radiotherapy.
DR GERRY HANNA
PUBLIC OUTREACH AND KEY ACHIEVEMENTS
PhD Title: New Preclinical Models for Personalised Radiotherapy in Non-Small Cell Lung Cancer
Name: Dr Victoria Dunne
Years of Study: 22014-2018
Country: United Kingdom